MMP-9和CD4^+/CD8^+在乳腺癌淋巴结转移过程中的作用被引量：2

The role of MMP-9 and CD4^+/CD8^+ in lymph node metastasis of breast cancer

导出

摘要目的探讨基质金属蛋白酶-9(MMP-9)的表达变化以及转移肿瘤周围CD4^+T细胞/CD8^+T细胞数量和比值在乳腺癌淋巴结转移发展过程中的作用。方法收集92例乳腺癌患者的腋窝淋巴结293枚。采用免疫组化的方法行细胞角蛋白19(CK-19)以及肌动蛋白染色,筛选出含有微转移、孤立肿瘤细胞的淋巴结。对筛选出的淋巴结行MMP-9、CD4及CD8染色,观察不同转移情况下MMP-9、CD4及CD8的表达情况。结果 293枚淋巴结中,明显转移的为84枚(28.67%),有微转移的为42枚(14.33%),孤立肿瘤细胞为22枚(7.51%);所有明显转移灶周围均有肌动蛋白表达,34枚(80.95%)含有微转移的淋巴结中微转移灶周围有肌动蛋白表达;84枚有明显转移的淋巴结中,MMP-9均呈阳性表达,其中66枚(78.57%)淋巴结高表达(卅),18枚(21.43%)为中度表达(++);42枚含有微转移的淋巴结中,1枚(2.38%)呈高表达(卅),24枚(57.14%)淋巴结呈中度表达(++),15枚(35.72%)淋巴结呈低表达(+),2枚(4.76%)淋巴结无表达。22枚孤立肿瘤细胞中,3枚(13.64%)呈低表达,其余19枚(86.36%)淋巴结无表达。CD4^+细胞表达率在有明显转移的淋巴结中明显高于微转移和无转移的淋巴结(P<0.05);CD8^+细胞在有明显转移、微转移及无转移淋巴结之间没有明显差异(P>0.05)。CD4^+/CD8^+在无转移的淋巴结明显低于有明显转移者(P<0.05)。结论 MMP-9的高表达可能是促进淋巴结内肿瘤细胞生长和侵袭的重要原因之一;肿瘤细胞可导致淋巴结癌转移灶局部CD4^+T淋巴细胞明显增多,导致CD4^+/CD8^+比值升高,提示机体在淋巴结局部对肿瘤细胞的免疫应答改变可能是肿瘤细胞得以发展的原因之一。 Objective To explore the expression and significance of MMP-9 and CD4 ^＋/CD8 ^＋ in lymph node metastasis of breast cancer. Methods Two hundred and ninety-three lymph nodes were collected from the axillary samples of 92 cases of breast cancer. The lymph nodes containing metastasis, micrometastases, or ITCS were detected by observing the expression of CK-19 and actin. The expressions of MMP-9, CD4 and CD8 were detected with immuohistochemistry method. Results Among the 293 lymph nodes, metastases were found in 84 nodes （28.67%） , micrometastases in 42 nodes （ 14.33% ） and ITCs in 22 nodes （7.51%）. The expression of MMP-9 was found in all metastasis nodes, and a high expression of MMP-9 was found in 66 nodes （ 78.57 % ）. Amany the 42 micrometastastic nodes, a high expression of MMP-9 was found in 1 node （2.38 % ） , middle expression in 18 nodes （21. 43%）, low expression in 15 nodes （35.72%）, and no expression in 2 nodes （4.76%）. Amany 22 nodes with ITCs, a low expression of MMP-9 was found in 3 nodes. The rate of CD4^ ＋ lymphocyte was significantly higher in metastastic group than in non-metastastic group and in the micrometasatis group （ P 〈 0.05 ）. There was a significant different rate of CD4 ^＋ T/CD8 ^＋ T between the metastastic and non-metastastic groups （ P 〈 0.05 ）. Conclusions The high expression of MMP-9 may enhance the capability of invasion and metastasis of tumor cells. CD4 ^＋ lymphocytes increase on the site of tumor cells in the lymph nodes region, which raises the ratio of CD4 ^＋ T/CD8 ^＋ T. The variation of immune response to tumor cells may be one cause to form the metastatic focus.

作者岳志强姜军范林军杨新华张毅

机构地区第三军医大学西南医院乳腺疾病中心

出处《中华乳腺病杂志（电子版）》 CAS 2007年第2期28-31,共4页 Chinese Journal of Breast Disease(Electronic Edition)

关键词乳腺癌淋巴结转移金属蛋白酶-9 CD4^+T淋巴细胞 CD8^+T淋巴细胞 Breast cancer Metastasis Matrix metalloproteinasc-9 CD4^＋ T lymphocytes CD8^＋ T lymphocytes

分类号 R737.9 [医药卫生—肿瘤]

引文网络
相关文献

参考文献6

1吴长有.初始和记忆T细胞的研究进展[J].现代免疫学,2005,25(5):353-356. 被引量：33
2Chagpar A B,,Kehdy F,Scoggins C R, et al.Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer[].The American Journal of Surgery.2005
3Greene FL,Page DL,Fleming ID,et al.AJCC cancer staging manual[]..2002
4Veronesi U,Marubini E,Mariani L,et al.The dissection of internal mammary nodes does not improve the survival of breast cancer patients.30-year results of a randomised trial[].European Journal of Cancer.1999
5AM Sieuwerts,JG Klijn,SC Henzen-Logman,I Bouwman,KE Van Roozendaal,HA Peters,B Setyono-Han,JA Foekens.Urokinase-type plasminogen activator (uPA) production by human breast (myo)fibroblasts in vitro: Influence of transforming growth factor-β1 (TGFβ1) compared with factor(s) released by human epithelial-carcinoma cells[].International Journal of Cancer.1998
6S Yoshioka,Y Fujiwara,Y Sugita.Real-time rapid reverse transcriptase-polymerase chain reaction for intraoperative diagnosis of lymph node micrometastasis: clinical application for cervical lymph node dissection in esophageal cancers[].Journal of Surgery.2002

二级参考文献17

1De Rosa SC, Herzenberg LA, Herzenberg LA,et al. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity[J]. Nat Med,2001, 7(2): 245-248.
2Masopust D, Kaech SM, Wherry E J, et al. The role of programming in memory T-cell developmemt [J]. Curr Opin Immunol, 2004, 16:217-225.
3Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets[J]. Nat Immunol, 2003,4:225-234.
4Lanzavecchia A, Sallusto F. Understanding the generation and function of memory T cell subsets[J]. Curr Opin Immunol, 2005,17:326-332.
5Wu CY, Kirman JR, Rotte MJ, et al. Distinct lineages of Th1cells have differential capacities for memory cell generation in vivo[J]. Nat Immunol, 2002,3:852-858.
6Sallusto F, Geinat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance[J]. Annu Rev Immunol, 2004,22: 745-763.
7Ley K, Kansas GS. Selectins in T-cell recruitment to nonlymphoid tissues and sites of inflammation [J]. Nature, 2004,4:1-11.
8Klebanoff CA, Gottinoni L, Torabi-Parizi P, et al. Central memory self/tumor-reactive CD8^+ T cells confer superior antitumor immunity compared with effector memory T cells[J]. PNAS, 2005, 102(27): 9571-9576.
9Marzo AL, Klonowski KD, Le Bon A, et al. Initial T cell frequency dicates memory CD8^+ T cell linage commitment[J]. Nat Immunol, 2005, 6(8):793-799.
10Seder RA , Ahmed R. Similarities and differences in CD4^+ and CD8^+ effector and memory T cell generation[J]. Nat Immunol Rev,2003,9:835-842.